Global OTC Topical Itch Relief Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global OTC Topical Itch Relief Market Research Report 2024
OTC Topical Itch Relief help to relieve itchy skin from bug bites, rashes & other minor skin irritations on the go.
According to Mr Accuracy reports’s new survey, global OTC Topical Itch Relief market is projected to reach US$ 180.5 million in 2029, increasing from US$ 130 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Topical Itch Relief market research.
Fungal infections are caused by various types of fungi and can occur on the skin, nails or hair. These infections are common health problems worldwide and can range from mild to severe. In the past few years, the prevalence of fungal infections is increasing due to factors such as environmental conditions and poor sanitation. Fungi thrive in warm, humid environments, and public facilities such as public swimming pools, changing rooms, and saunas increase the risk of infection. Due to the sub-health state and the weakening of body resistance, the scope of skin disease infection is expanding day by day. The elderly, children, young people, and adults all have skin diseases more or less, and they cannot be cured. The itching will always accompany, which also makes over-the-counter Anti-itch products saw growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Topical Itch Relief market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Cortizone
Benadryl
Walgreens
Bepanthen
BuzzRx
Eurax
Gold Bond(Sanofi Consumer Healthcare)
MSKTC
POLYSPORIN
CeraVe
Canesten
Allegra
Vanicream
Hydrocortisone
Segment by Type
Creams
Lotions
Gels & Ointments
Liquid
Hospital
Pharmacy
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The OTC Topical Itch Relief report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global OTC Topical Itch Relief market is projected to reach US$ 180.5 million in 2029, increasing from US$ 130 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Topical Itch Relief market research.
Fungal infections are caused by various types of fungi and can occur on the skin, nails or hair. These infections are common health problems worldwide and can range from mild to severe. In the past few years, the prevalence of fungal infections is increasing due to factors such as environmental conditions and poor sanitation. Fungi thrive in warm, humid environments, and public facilities such as public swimming pools, changing rooms, and saunas increase the risk of infection. Due to the sub-health state and the weakening of body resistance, the scope of skin disease infection is expanding day by day. The elderly, children, young people, and adults all have skin diseases more or less, and they cannot be cured. The itching will always accompany, which also makes over-the-counter Anti-itch products saw growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Topical Itch Relief market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Cortizone
Benadryl
Walgreens
Bepanthen
BuzzRx
Eurax
Gold Bond(Sanofi Consumer Healthcare)
MSKTC
POLYSPORIN
CeraVe
Canesten
Allegra
Vanicream
Hydrocortisone
Segment by Type
Creams
Lotions
Gels & Ointments
Liquid
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The OTC Topical Itch Relief report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source